A

A Machine Learning Algorithm to Identify Patients with Possible Non-Dialysis-Dependent CKD

Journal of the American Society of Nephrology, vol. 32, pp. 716–717

Abstract

Background: The DAKOTAH study is a retrospective study of patients with non-dialysis-dependent chronic kidney disease (NDD CKD) in France based on data from the Echantillon Généraliste des Bénéficiaires database. A stepwise machine learning approach was used to identify patients with possible NDD CKD who could not be captured using the NDD CKD case definition (Figure). Methods: First, the ‘potential CKD’ population was designated as patients with a diagnosis of diabetes, cardiovascular disease or hypertension, or with ≥3 prescriptions for antidiabetic and/or antihypertensive drugs, during 2012-2017. Second, an unsupervised algorithm was trained to identify patients very likely to have CKD (‘possible CKD’) in the potential CKD population. Similarity between patients was based on CKD-related variables: sex; number and duration of hospitalizations for renal failure; number of GP visits; medications; and biological exams. A distance metric between patients was defined based on these variables, and patients having similar characteristics were positioned close to one another. The algorithm learned to construct a spherical boundary around the non-CKD population, to create a decision rule for possible CKD versus non-CKD, with outliers considered possible CKD. Results: The algorithm was validated by application to both the potential CKD population and a confirmed CKD patient pool. From the potential and confirmed CKD populations, 21% and 65% of patients were classified as possible CKD, respectively. Similarities were observed between the two groups regarding hospitalizations and selected biological exams. Conclusions: This machine learning-derived decision rule could be a tool to identify undiagnosed patients with NDD CKD. Funding: Commercial Support - Astellas Pharma Inc.

Authors 7

  1. Centre Hospitalier Universitaire de Caen Normandie

    Affiliation as printed

    University Hospital, Caen, France;

  2. Affiliation as printed

    Association Limousine pour l'Utilisation du Rein Artificiel à Domicile (ALURAD), Limoges, France;

  3. Affiliation as printed

    HEVA, Lyon, France;

  4. Affiliation as printed

    HEVA, Lyon, France;

  5. Centre Hospitalier de la Côte Basque

    Affiliation as printed

    Centre Hospitalier de la Côte Basque, Bayonne, France;

  6. Affiliation as printed

    Astellas Pharma Europe, Levallois-Perret, France;

  7. Astellas Pharma (Netherlands)

    Affiliation as printed

    Astellas Pharma Europe B.V., Leiden, Netherlands

Cited by 0 stored of 0

No patents citing this paper on Lens.org (checked 2026-10-11).

References 0